Essential tremor (ET) is a brain condition that causes uncontrollable shaking of the hands, head, and voice. In some cases, it can also cause your legs and trunk to shake. Also called benign essential ...
Essential tremor (ET), a neurological disorder characterized by involuntary, rhythmic shaking of the hands and head, is one of the most common movement disorders, affecting an estimated 2.2% of the ...
Doctors at Henry Ford Hospital are using a new, incision-free brain treatment that can virtually eliminate a tremor in real ...
Propranolol and Primidone demonstrate efficacy in up to 70% of patients as first-line agents. MR-Guided Focused Ultrasound (MRgFUS) results in approximately 56% tremor reduction at 4 years. Deep Brain ...
This article was written for our sponsor, Essential Tremor Products. Imagine trying to do simple tasks like buttoning a shirt, stirring a cup of coffee or brushing your teeth, but being unable to do ...
This week we are going to discuss something which is quite common and problematic for patients which is only recently beginning to show some receptiveness to treatment. The condition: essential tremor ...
Treatment options for essential tremor include medications, exercises, lifestyle changes, and in severe cases, surgical procedures such as deep brain stimulation. Essential tremor is a neurological ...
Cala Health announces real-world evidence from three months of home-use by patients prescribed Cala Trio to treat their essential tremor BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a ...
Hosted on MSN
Praxis Precision’s tremor-drug trial succeeds where others have failed. The stock is skyrocketing.
Shares of biopharmaceutical company Praxis Precision Medicines Inc. soared Thursday, boosted by the successful trial of a new drug to treat movement disorders. The drug, ulixacaltamide, targets ...
Add Yahoo as a preferred source to see more of our stories on Google. Finding part of your body shaking involuntarily can be distressing, especially when there’s no clear cause. Hand tremors, for ...
Praxis Precision Medicines’ commitment to forging ahead with ulixacaltamide in essential tremor (ET) has paid off. After brushing off a recommendation to end a phase 3 study earlier this year based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results